الفهرس 
INTRODUCTION & AIM OF THE WORKOnly 14 pages are availabe for public view
 |  | from | 137 |  |  |
| | | from | 137 | | |
Abstract
Acquired immunodeficiency syndrome (AIDS) is
one of the most important problems for medical practitioners.
This syndrome was first recognized in 1981,
(C.D.C. 1981), and reported
1983, (Barre-Sinoussi et al
a retrovirus called human
(HIV) (Levy, et al, 1984),
as a viral disease in
1983). It is caused by
immunodeficiency virus
which infects T helper
lymphocytes, causing T dysfunction and depletion
resulting in opportunistic infections, Kaposi sarcoma
and other neoplasm (Gallo, et al, 1982).
Primary methods of transmission are by sexual
contact, blood products, intravenous inoculations
with contaminated needles or in utero infection,
homosexual men, intravenous drug users and hemophiliacs
being the classic risk group (Curran, 1985).
It is possible that patients undergoing hemodialysis
treatment, who need multiple transfusions for
anemia or preparation for renal transplantation,
run a higher risk of acquiring the infection (Peterman,
et al, 1986). However there is no evidence to date that- 2 -
AID has been contracted by a patient during HD,
which could depend on the low infectivity and lability
of HIV (Poole, et al, 1985). Renal transplantation
from infected donors could be another vehicle of
transmission.
the prevalence of human immunodeficiency virus
(HIV) among patients undergoing maintenance hemodialysis
varies in different geographic areas (Morrison, et
al, 1986).
Screening for antibody to HTLV-111/LAV in dialysis
centres is important as a help in prevention of infection
(Peterman et al, 1986). So to obtain more precise
information on the prevalence of acquired immunodeficiency
syndrome in patients undergoing hemodialysis.
We have conducted a controlled serological and clinical
study involving a reasonable number of patients ..
Aim of the Work:
Study the prevalance of HTLV-III infection
in patients with chronic renal failure under regular
hemodialysis.